897 total citations 37 papers, 596 citations indexed
About
Oldham Rk is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biotechnology.
According to data from OpenAlex, Oldham Rk has authored 37 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Biotechnology. Recurrent topics in Oldham Rk's work include Cancer Research and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (3 papers). Oldham Rk is often cited by papers focused on Cancer Research and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (3 papers). Oldham Rk collaborates with scholars based in United States. Oldham Rk's co-authors include Greco Fa, Richardson Rl, Leslie Burnett, R B Herberman, A E Maluish, West Wh, Thelma M. Watson, Richard D. Leavitt, Robert Birch and Chantal Moratz and has published in prestigious journals such as Seminars in Oncology, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Oldham Rk
34 papers
receiving
507 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Oldham Rk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oldham Rk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oldham Rk more than expected).
This network shows the impact of papers produced by Oldham Rk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oldham Rk. The network helps show where Oldham Rk may publish in the future.
Co-authorship network of co-authors of Oldham Rk
This figure shows the co-authorship network connecting the top 25 collaborators of Oldham Rk.
A scholar is included among the top collaborators of Oldham Rk based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Oldham Rk. Oldham Rk is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Rk, Oldham. (1991). Cancer research: a public trust.. PubMed. 3(3). 122–3.
2.
Rk, Oldham. (1991). Custom-tailored drug immunoconjugates in cancer therapy.. PubMed. 3(3). 148–62.7 indexed citations
3.
Rk, Oldham, et al.. (1991). Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group Trial.. PubMed. 3(2). 68–73.13 indexed citations
4.
Wh, West, et al.. (1989). Multiple cycles of constant infusion recombinant interleukin-2 in adoptive cellular therapy of metastatic renal carcinoma.. PubMed. 1(5). 268–74.9 indexed citations
5.
Rk, Oldham, et al.. (1989). Chemosensitivity testing in a tumor acquisition, propagation, and preservation program.. PubMed. 1(5). 256–60.4 indexed citations
6.
Rk, Oldham. (1987). Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application?. PubMed. 6(3). 227–34.5 indexed citations
7.
Rk, Oldham, et al.. (1986). Phase I trials of biological response modifiers.. PubMed. 12(1-3). 31–9.3 indexed citations
8.
Rk, Oldham. (1985). Interferon: a model for future biologicals.. PubMed. 6. 127–43.6 indexed citations
9.
Maluish, A E, et al.. (1984). A trial of autologous plasma perfusion over protein A in patients with breast cancer.. PubMed. 3(3). 352–8.10 indexed citations
10.
Watson, Thelma M., et al.. (1984). A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.. PubMed. 3(6). 599–607.19 indexed citations
11.
Rk, Oldham, et al.. (1983). Interferon as a biological response modifying agent in clinical trials.. PubMed. 2(5). 401–8.15 indexed citations
12.
Rk, Oldham, et al.. (1983). Immunotherapy: the old and the new.. PubMed. 2(1). 1–37.32 indexed citations
13.
Rk, Oldham. (1983). Biologicals: new horizons in pharmaceutical development.. PubMed. 2(3). 199–206.6 indexed citations
14.
Leavitt, Richard D., et al.. (1983). Effects of recombinant interferon-alpha on immune function in cancer patients.. PubMed. 2(5). 470–81.11 indexed citations
15.
Rk, Oldham. (1982). Biological Response Modifiers Programme and cancer chemotherapy.. PubMed. 4(3). 173–88.3 indexed citations
16.
Rl, Richardson, et al.. (1978). Tumor products and potential markers in small cell lung cancer.. Seminars in Oncology. 5(3). 253–62.41 indexed citations
17.
Fa, Greco, et al.. (1978). Small cell lung cancer: progress and perspectives.. PubMed. 5(3). 323–35.81 indexed citations
18.
Wj, Catalona, et al.. (1975). Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26. 122–124.4 indexed citations
19.
Rk, Oldham, et al.. (1974). Possible role of lymphocyte cytotoxicity in bone-marrow grafting.. PubMed. 6(4). 417–9.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.